Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03342937 |
|---|---|
| Brief Title: | KeyLargo: Pembrolizumab + Oxaliplatin + Capecitabine in Gastric Cancer |
| First Submitted : | November 10, 2017 |
| First Submitted that Met QC Criteria : | November 10, 2017 |
| First Posted : | November 17, 2017 |
| Last Update Submitted that Met QC Criteria : | March 28, 2019 |
| Last Update Posted : | March 29, 2019 |